Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy ; volume:15 ; number:1 ; day:27 ; month:9 ; year:2024 ; pages:1-16 ; date:12.2024
Nature Communications ; 15, Heft 1 (27.9.2024), 1-16, 12.2024
- Urheber
-
Maliah, Avishai
Santana-Magal, Nadine
Parikh, Shivang
Gordon, Sagi
Reshef, Keren
Sade, Yuval
Khateeb, Aseel
Richter, Alon
Gutwillig, Amit
Parikh, Roma
Golan, Tamar
Krissi, Matan
Na, Manho
Binshtok, Gal
Manich, Paulee
Elkoshi, Nadav
Grisaru-Tal, Sharon
Zemser-Werner, Valentina
Brenner, Ronen
Vaknine, Hananya
Nizri, Eran
Moyal, Lilach
Amitay-Laish, Iris
Rosemberg, Luiza
Munitz, Ariel
Kronfeld-Schor, Noga
Shifrut, Eric
Kobiler, Oren
Madi, Asaf
Geiger, Tamar
Carmi, Yaron
Levy, Carmit
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-52079-x
- URN
-
urn:nbn:de:101:1-2412132112389.257555472318
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maliah, Avishai
- Santana-Magal, Nadine
- Parikh, Shivang
- Gordon, Sagi
- Reshef, Keren
- Sade, Yuval
- Khateeb, Aseel
- Richter, Alon
- Gutwillig, Amit
- Parikh, Roma
- Golan, Tamar
- Krissi, Matan
- Na, Manho
- Binshtok, Gal
- Manich, Paulee
- Elkoshi, Nadav
- Grisaru-Tal, Sharon
- Zemser-Werner, Valentina
- Brenner, Ronen
- Vaknine, Hananya
- Nizri, Eran
- Moyal, Lilach
- Amitay-Laish, Iris
- Rosemberg, Luiza
- Munitz, Ariel
- Kronfeld-Schor, Noga
- Shifrut, Eric
- Kobiler, Oren
- Madi, Asaf
- Geiger, Tamar
- Carmi, Yaron
- Levy, Carmit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling
CD8+ T cell-based cancer immunotherapy
SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy
Metabolically targeting immunosuppression and immunoescape for future cancer immunotherapy: a narrative review
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Rheumatoid arthritis reprograms circadian output pathways
Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
Metabolically induced neuronal differentiation
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
LMO3 reprograms visceral adipocyte metabolism during obesity
Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling
CD8+ T cell-based cancer immunotherapy
SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy
Metabolically targeting immunosuppression and immunoescape for future cancer immunotherapy: a narrative review
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Rheumatoid arthritis reprograms circadian output pathways
Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
Metabolically induced neuronal differentiation
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
LMO3 reprograms visceral adipocyte metabolism during obesity
Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling
CD8+ T cell-based cancer immunotherapy
SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy
Metabolically targeting immunosuppression and immunoescape for future cancer immunotherapy: a narrative review
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Rheumatoid arthritis reprograms circadian output pathways
Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
Metabolically induced neuronal differentiation
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy